Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring.

Barrado, Marta; Blanco-Luquin, Idoia; Navarrete, Paola Andrea; Visus, Ignacio; Guerrero-Setas, David; Escors, David; Kochan, Grazyna; Arias, Fernando

Barrado, Marta; Blanco-Luquin, Idoia; Navarrete, Paola Andrea; Visus, Ignacio; Guerrero-Setas, David; Escors, David; Kochan, Grazyna; Arias, Fernando.

Afiliação

Barrado M; Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Blanco-Luquin I; Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Navarrete PA; Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Visus I; Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Guerrero-Setas D; Department of Radiation Oncology, Hospital of Navarre, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Escors D; Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Kochan G; Biomedical Research Center of Navarra-Navarrabiomed, Fundación Miguel Servet, IdISNA, Irunlarrea 3, 31008 Pamplona, Navarre, Spain.
Arias F; Department of Infection and Immunity, Rayne Institute, University College London, 5 University Street, WC1E 6JJ London, United Kingdom.

Rep Pract Oncol Radiother ; 24(2): 221-226, 2019.

Article em En | MEDLINE | ID: mdl-30858765

Palavras-chave

Androgen blockade; Apoptosis; Enzalutamide; Prostate cancer; Radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rep Pract Oncol Radiother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google